Neurology

• B.A., Johns Hopkins University, 1991
• M.D., Vanderbilt University School of Medicine, 1995
• Internship, Internal Medicine, Duke University Medical Center, 1995-1996
• Residency, Neurology, Duke University Medical Center, 1996-1999
• Fellowship, Division of Epilepsy, Mayo Clinic, 1999-2001
• Certification, American Board of Clinical Neurophysiology, 2001; American Board of Psychiatry and Neurology, with added qualifications in Clinical Neurophysiology, 2001
• License, Missouri State, Minnesota State, and New York State

• American Academy of Neurology, 1997-present
• American Medical Association, 1994-present
• American Epilepsy Society, 1998-present
• American Sleep Disorders Association, 1998-1999

• Automated Response to Spontaneous Epileptiform Activity using the External Responsive Neurostimulator System (Neuropace, Inc.)
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM927 (200 mg/ay, 400 mg/day, 600 mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization, Protocol #SP667 (Schwarz Pharma)
• An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients with Partial Seizures, Protocol #SP615 (Schwarz Pharma)
• Early Randomized Surgical EPilepsy Trial (ERSET) - NIH/NINDS (PI for initial year)
• Efficacy of Lamotrgine in the Treatment of Interictal Dysphoric Disorder with or without Postictal Depressive Symptoms in Patients with EPilepsy (Glaxo Smith Kline)
• A Randomized, Double-Blind, Crossover Comparison of the Cognitive and Behavioral Effects of Lamotrigine and Topiramate in Healthy Adults (Glaxo Smith Kline)
• A Multicenter, Open-Label, Phase IV Study to Assess the Tolerability, Safety and Effectiveness of Switching from Carbemazepine Immediate Release and Liquid Formulations to Carbatrol (Shire)

• Human Studies Committee - Continuing Review, Washington University School of Medicine
• Professional Advisory Board, St. Louis Chapter, Epilepsy Foundation
• Ad hoc reviewer: Epilepsia and Mayo Clinic Proceedings
• Alumni Interviewer, Office of Admissions, Johns Hopkins University

Teaching/Lecturing:

• Teaching of Neurology residents and Clinical Neurophysiology/Epilepsy Fellows
• Medical Student teaching in Diseases of the Nervous System (2nd year course)
• CME Programs:
  • Pediatric and Adult Neurotherapeutics: June 2003, Washington University School of Medicine
  • Neurotherapeutics and the Elderly: November 2002, Washington University School of Medicine
• Grand Rounds:
  • Washington University School of Medicine, St. Louis, MO
  • Monmouth Regional Medical Center, Monmouth, NJ
  • Mayo Clinic, Scottsdale, AZ
• Industry Speaker's Bureau or Programs:
  • UCB Pharma
  • Ortho McNeil
  • Pfizer